Day: March 5, 2024

Kevin BeckerKevin Becker promoted to Chief Credit OfficerARCHBOLD, Ohio, March 05, 2024 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced the promotion of Kevin Becker to Senior Vice President and Chief Credit Officer. Lars Eller, President and Chief Executive Officer stated, “We are thrilled to announce the promotion of Kevin Becker to Chief Credit Officer, a testament to our belief in fostering talent from within and recognizing the hard work and dedication that he has consistently demonstrated. Kevin’s profound understanding of our credit operations and unwavering commitment to our values of integrity and excellence have been instrumental in driving our success.” Mr. Becker began his career at F&M in 2015 and...

BRENTWOOD, Tenn., March 05, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it successfully upsized and priced its offering of $500 million aggregate principal amount of 8.25% senior notes due 2029 (the “Notes”). The aggregate principal amount of the Notes to be issued in the offering was increased to $500 million from the previously announced $450 million. The Notes will be senior unsecured obligations of CoreCivic and will be guaranteed on a senior unsecured basis by all of CoreCivic’s subsidiaries that guarantee its existing senior secured credit facilities, 4.75% senior unsecured notes due October 2027 and 8.25% senior unsecured notes due 2026 (the “2026 Notes”). The aggregate net proceeds from the sale of the Notes are expected to be approximately $490.3 million, after deducting the underwriting...

Preclinical data support future clinical development of ADCs targeting Claudin-6 and NaPi2b Additional presentations include clinical and independent preclinical studies evaluating ADCT-601 targeting AXL LAUSANNE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced abstracts on its novel antibody drug conjugates (ADCs) have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting, which will be held in San Diego, CA from April 5-10, 2024. “We’re excited to share compelling preclinical data supporting the future clinical development of the next-generation ADCs in our solid tumor portfolio, including those targeting Claudin-6 and NaPi2b, at the AACR Annual Meeting,” said Mohamed Zaki, MD, PhD, Chief Medical Officer of ADC Therapeutics. “We’re...

NEWARK, NJ, March 05, 2024 (GLOBE NEWSWIRE) — Genie Energy Ltd., (NYSE: GNE, GNEPRA), a leading retail energy and renewable energy solutions provider, will announce financial and operational results for the fourth quarter and full year 2023 on Monday, March 11, 2024. Genie Energy will issue an earnings release over a wire service and post it in the “Investors” section of the Genie Energy website (https://genie.com/investors/quarterly-earnings/) at 7:30 AM Eastern. The release also will be filed in a current report (Form 8-K) with the SEC. At 8:30 AM Eastern, Genie Energy’s management will host a conference call to discuss financial and operational results, business outlook, and strategy. The call will begin with management’s remarks followed by Q&A with investors. To participate in the conference call, dial 1-877-545-0523...

– Increased Energized Hash Rate 9% M/M to 28.7 EH/s – Increased BTC Holdings to 16,930 BTC; Total Cash and BTC of $1.5B as of February 29, 2024 Fort Lauderdale, FL, March 05, 2024 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), a leader in supporting and securing the Bitcoin ecosystem, today published unaudited bitcoin (“BTC”) production and miner installation updates for February 2024. Management Commentary“The operational challenges that commenced in January, continued into February and reduced our operational hash rate and our bitcoin production for the month,” said Fred Thiel, Marathon’s chairman and CEO. “The Garden City and Ellendale sites, which are operated by Applied Digital and collectively represent approximately 43% of our energized hash...

TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a proposed private placement (the “Private Placement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia. Per the terms of the Private Placement, ThreeD will acquire 3,750,000 common shares of Sariel at a price of $0.02 per share. In consideration, ThreeD will issue an aggregate of 150,000 common shares of the Company at a deemed price of $0.50 per common share. The Private Placement remains subject to the approval of the Canadian Securities Exchange. About ThreeD Capital...